Veterinary Sciences (Jan 2024)

Pilot Study on QTc Interval in Dogs Treated with Domperidone

  • Giulia Donato,
  • Tiziana Caspanello,
  • Massimo De Majo,
  • Marisa Masucci,
  • Diego Iannelli,
  • Silvia Santoro,
  • Alessandra Caprì,
  • Nicola Maria Iannelli,
  • Maria Grazia Pennisi

DOI
https://doi.org/10.3390/vetsci11010039
Journal volume & issue
Vol. 11, no. 1
p. 39

Abstract

Read online

Domperidone is used as an immunomodulatory drug for Leishmania infantum infection and disease in dogs. However, a pro-arrhythmic side effect, caused by prolonged QT intervals, is reported in humans. This pilot study evaluated the corrected QT (QTc) interval in dogs treated with domperidone for preventive or therapeutic management of leishmaniosis. The electrocardiogram and blood concentration of creatinine, urea nitrogen, sodium, potassium, and chloride were evaluated seven days before the start and on the last day of therapy in 17 dogs receiving domperidone for four weeks. In two dogs, the QTc interval was measured before and 2 h, 3 h, and 12 h after administration of the drug on the first day of treatment. After treatment, QTc measures and chloride concentrations increased significantly, although the QTc value slightly exceeded the upper reference limit only in one dog, and chloride concentrations were always normal. Creatinine concentrations significantly decreased after therapy. In the two dogs monitored at different times on the first day of treatment, QTc values were always normal. Domperidone caused a slight prolongation of QTc interval, and further studies should be made for a risk assessment in dogs with cardiac diseases, electrolytic imbalance, and in those receiving drugs increasing QT interval or competing with domperidone metabolism.

Keywords